- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00026013
Effects of St. John's Wort on the Effectiveness of Oral Contraceptives
August 17, 2006 updated by: National Center for Complementary and Integrative Health (NCCIH)
Effects of Hypericum Perforatum on Effectiveness of Oral Contraceptives
The purpose of this study is to evaluate the effects of a common herbal remedy, St. John's Wort, on the effectiveness of birth control pills.
St. John's Wort has recently been shown to increase metabolism of some drugs.
If it could increase metabolism of oral contraceptives as well, it may increase the risk of contraceptive failure and unintended pregnancy.
Study participants will be evaluated for risk of ovulation on oral contraceptives before and during simultaneous therapy with St. John's Wort.
Study Overview
Detailed Description
See Brief Summary
Study Type
Interventional
Enrollment
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Department of Obstetrics & Gynecology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 36 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women taking or willing to take low dose oral contraceptives for 5 months
- No contraindications to hormonal contraception
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Patricia Murphy, DrPh, Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2002
Study Completion
January 1, 2004
Study Registration Dates
First Submitted
November 5, 2001
First Submitted That Met QC Criteria
November 5, 2001
First Posted (Estimate)
November 6, 2001
Study Record Updates
Last Update Posted (Estimate)
August 18, 2006
Last Update Submitted That Met QC Criteria
August 17, 2006
Last Verified
July 1, 2006
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- R21AT000836-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Montefiore Medical CenterSociety of Family PlanningCompletedContraception | Breastfeeding | Postpartum ContraceptionUnited States
Clinical Trials on hypericum perforatum
-
Prof. Eldad YechiamBeer Yaakov - Ness Ziona Mental Health CenterCompletedHealthy Adults | Subclinical Anxious Adults | Nootropic Potential of Hypericum and AlprazolamIsrael
-
National Center for Complementary and Integrative...CompletedAnxiety Disorders | Mental HealthUnited States
-
National Center for Complementary and Integrative...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Uskudar UniversityCompleted
-
University of Split, School of MedicineCompletedEffects of Hypericum Perforatum Oil on Promoting Skin Recovery in Different Human Skin Damage ModelsSkin Recovery in Different Human Skin Damage ModelsCroatia
-
Mayo ClinicCompletedIrritable Bowel SyndromeUnited States
-
AstraZenecaQuintiles, Inc.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnAdult Solid Tumor | Breast Cancer | Head and Neck Cancer | Kidney and Urinary Cancer | Male Reproductive Cancer | Thorax and Respiratory Cancer
-
University Hospital, GrenobleTerminated
-
Ataturk UniversityCompletedPalate; Wound | Wound Healing DisorderTurkey